Evidence map›Paper›PMID 31198785›Full record

SynthesisBioMed research international2019

Differences in Leukocyte Telomere Length between Coronary Heart Disease and Normal Population: A Multipopulation Meta-Analysis.

Xiaofeng Xu, Haochang Hu, Ying Lin, Fangzhong Huang, Huihui Ji, Yin Li, Shaoyi Lin, Xiaomin Chen, Shiwei Duan

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Allogeneic Transplantation for Older Adults.Advances in experimental medicine and biology · 2025
    Review
  5. Article
  6. The Role of Estrogen across Multiple Disease Mechanisms.Current issues in molecular biology · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Telomere Length: A Cardiovascular Biomarker and a Novel Therapeutic Target.International journal of molecular sciences · 2022
    Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaofeng XuMedical Genetics Center, School of Medicine, Ningbo University, Ningbo 315000, Zhejiang, China.ORCID 0000-0002-3998-9245
Haochang HuMedical Genetics Center, School of Medicine, Ningbo University, Ningbo 315000, Zhejiang, China.
Ying LinMedical Genetics Center, School of Medicine, Ningbo University, Ningbo 315000, Zhejiang, China.
Fangzhong HuangMedical Genetics Center, School of Medicine, Ningbo University, Ningbo 315000, Zhejiang, China.
Huihui JiMedical Genetics Center, School of Medicine, Ningbo University, Ningbo 315000, Zhejiang, China.
Yin LiMedical Genetics Center, School of Medicine, Ningbo University, Ningbo 315000, Zhejiang, China.
Shaoyi LinKey Laboratory of Ningbo First Hospital and Cardiovascular Center of Ningbo First Hospital, Ningbo University, Ningbo 315000, Zhejiang, China.
Xiaomin ChenKey Laboratory of Ningbo First Hospital and Cardiovascular Center of Ningbo First Hospital, Ningbo University, Ningbo 315000, Zhejiang, China.ORCID 0000-0003-1498-0452
Shiwei DuanMedical Genetics Center, School of Medicine, Ningbo University, Ningbo 315000, Zhejiang, China.ORCID 0000-0001-7682-2877

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronary heart disease (CHD) is one of the most common causes of death in the world. Numerous studies have shown that as the degree of atherosclerotic disease increases, leukocyte telomere length gradually decreases. Short telomeres increase the risk of all-cause death and cardiovascular death. However, the reported results are not consistent, since the experimental design method, the measurement method, and the disease outcome are different. Therefore, we searched five major literature databases (Pubmed, Web of science, Embase, CNKI, and Wangfang) and finally included 18 eligible articles (including 5,150 patients with CHD and 9341 controls). We found that telomere length in patients with CHD was significantly shorter than that in controls, and the telomere length was inversely correlated with the severity of CHD. Subgroup analysis showed that telomere shortening was the most significant in Asian patients with CHD, in CHD patients with an average age <65 years, and in men with CHD. The mechanism of shortening the telomere length leading to the occurrence and development of CHD is worthy of further study.

Indexed as

Telomere ShorteningCoronary DiseaseFemaleHumansMaleSeverity of Illness IndexTelomere

Identifiers

PMID31198785
PMCPMC6526555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.